Molecular Neurodegeneration
@MolNeuro
The #1 open-access peer-reviewed neuroscience journal with a 2024 Impact Factor of 17.5 and a 5-year IF of 19.3. Official journal of BrightFocus Foundation
'#Endothelium-specific endoglin triggers #astrocyte reactivity via #extracellularvesicles in a mouse model of #AlzheimersDisease' Pingao Zhang, Chenghuan Song...Yongfang Zhang, Hongzhuan Chen, Hao Wang …arneurodegeneration.biomedcentral.com/articles/10.11…
Excited to share my last publication with @LuVaDeBo published in @MolNeuro. Our review explores emerging evidence on how disruptions in glycerophospholipid metabolism contribute to ALS pathogenesis. #ALS #motorneuron #lipidmetabolism …arneurodegeneration.biomedcentral.com/articles/10.11…
'The role of #endolysosomal #progranulin and #TMEM106B in neurodegenerative diseases' Hideyuki Takahashi & Stephen M. Strittmatter @YaleMed …arneurodegeneration.biomedcentral.com/articles/10.11…
'Glycerophospholipids in #ALS: insights into disease mechanisms and clinical implication' Thibaut Burg @Thibaut_Burg & Ludo Van Den Bosch @LuVaDeBo #LipidMetabolism @leuvenbrainins1 @KU_Leuven …arneurodegeneration.biomedcentral.com/articles/10.11…
We are thrilled that Dr Pete Williams of Karolinska Institute will be our next webinar speaker! From bench to bedside and back again: Targeting NAD for neuroprotection in #glaucoma Aug 11, 2025 10-11am ET Host: Dr Diane Bovenkamp @_BrightFocus Register: bit.ly/4o6WrqY
🚨 New publication alert 🚨 Happy to share that our work on the brain DNA methylation landscape of FTLD-TDP patients is now out in Molecular Neurodegeneration 🧠 Want to know more? Read the full article here 👇🏼
Methylome analysis of #FTLD patients with #TDP43 pathology identifies #epigenetic signatures specific to pathological subtypes Cristina T. Vicente, Tejasvi Niranjan, Elise Coopman...Rosa Rademakers @CMN_VIB @MayoClinicNeuro …arneurodegeneration.biomedcentral.com/articles/10.11…
'#Proteomic landscape of #AlzheimersDisease: emerging technologies, advances and insights (2021 – 2025)' Jay M. Yarbro, Him K. Shrestha...Junmin Peng @JunminPengLab @StJudeStructBio @StjudeResearch …arneurodegeneration.biomedcentral.com/articles/10.11…
'#Biomarkers and therapeutic strategies targeting microglia in #neurodegenerative diseases: current status and future directions' Min-Young Noh, Hyuk Sung Kwon, Min-Soo Kwon, Minyeop Nahm...Seung Hyun Kim @i_hanyang #microglia …arneurodegeneration.biomedcentral.com/articles/10.11…
'#Glial #phagocytosis for synapse and toxic proteins in #neurodegenerative diseases' Yeseong Choi & Won-Suk Chung @wonsukchung @kaistpr …arneurodegeneration.biomedcentral.com/articles/10.11…
Methylome analysis of #FTLD patients with #TDP43 pathology identifies #epigenetic signatures specific to pathological subtypes Cristina T. Vicente, Tejasvi Niranjan, Elise Coopman...Rosa Rademakers @CMN_VIB @MayoClinicNeuro …arneurodegeneration.biomedcentral.com/articles/10.11…
'Skin biopsy: an emerging tool for the diagnosis of #proteinmisfolding diseases of the central nervous system' Wei Zhu, Hao-Lun Sun, Yan-Jiang Wang, Xia Lei, Xian-Le Bu #alphasynuclein #neurodegeneration …arneurodegeneration.biomedcentral.com/articles/10.11…
'Current strategies in the management of #dementia with #lewybodies and future directions based on disease pathophysiology' Daniel Erskine & John-Paul Taylor @John_PaulTaylor @UniofNewcastle …arneurodegeneration.biomedcentral.com/articles/10.11…
'Alpha-#synuclein seeding amplification assays in #Lewybodydementia: a brief review' Maria Bregendahl, Zeynep Bengisu Kaya, Wolfgang Singer, Pamela J. McLean @MayoClinicNeuro #synucleinopathies #biomarker …arneurodegeneration.biomedcentral.com/articles/10.11…
Happening now!
We are thrilled that Dr Andrew Yoo @washumedicine will be our next webinar speaker! Title: Modeling aging as a risk factor for late-onset #AlzheimersDisease June 30, 2025 10 - 11 AM (ET) Host: Guojun Bu, Ph.D. Register: bit.ly/448dFMK
We're proud to share that Molecular Neurodegeneration (MN), the official scientific journal of BrightFocus Foundation, has reached an impact factor of 17.5—a 17% increase over the previous year’s impact factor of 14.9! 🎉 @MolNeuro has been the #1 open-access neuroscience…
📢 Final Call for Abstracts – ISMND NextGen 2025 The final abstract submission deadline has been extended to June 30! Don’t miss your chance to present your research at a virtual conference for early-career researchers! ismnd.org/conferences/ne…
🚨 Big news! 🚨 Our 2024 Impact Factor is 17.5 🎉 We're now ranked #4 out of 314 neuroscience journals and proudly remain the #1 open-access, peer-reviewed journal in neuroscience 🧠✨ A huge thank you to our editors, authors, @_BrightFocus and readers for their support!
'The PKCι-β-arrestin2 axis disrupts SORLA retrograde trafficking, driving its degradation and #amyloid pathology in #Alzheimersdisease' Hasibur Rehman, Shun Yan, Shalini Saggu...Qin Wang @MCG_AUG @AUG_University …arneurodegeneration.biomedcentral.com/articles/10.11…
'Mechanisms of interventions targeting modifiable factors for #dementia risk reduction' Anna Matton, Ruth Stephen, Makrina Daniilidou ...Miia Kivipelto @MiiaKivipelto @karolinskainst …arneurodegeneration.biomedcentral.com/articles/10.11…
'Clinical progression and genetic pathways in body-first and brain-first #Parkinsons disease' Massimiliano Passaretti, Daniel Veréb, Mite Mijalkov...Joana B. Pereira …arneurodegeneration.biomedcentral.com/articles/10.11…
